A 59-year-old man suffering from chronic bronchitis, arteritis of the lower limbs, and ischemic
heart disease was admitted for pulmonary edema. He had no symptom of right heart failure …

A patient with acute changes suggesting acute hepatitis after parenteral amiodarone
administration is described. A 77‐year‐old man with previous myocardial infarction was …

Two patients with acute changes suggesting acute hepatitis after parenteral amiodarone
administration are described. No other explanation for liver damage was found in these …

A 61 year old man, treated with amiodarone since 1993 for resistant supraventricular
arrhythmias, developed acute hepatitis after an intravenous amiodarone administration …

In April 2002, an 83-year-old woman was admitted in emergency with an 8-hour history of
dyspnea and palpitations. The patient referred a diagnosis of cardiomyopathy 6 months …

Acute hepatitis after parenteral amiodarone Page 1 Br Heart J 1988;59:690-1 Acute
hepatitis after parenteral amiodarone adnministration M PYE, Rj NORTHCOTE, SM COBBE …

Amiodarone is a class III antiarrhythmic drug widely used for the treatment of both
supraventricular and ventricular arrhythmias in intensive care unit. Hepatotoxicity of …

Amiodarone is a class III antiarrhythmic agent with a long half-life which is used to control
atrial and ventricular arrhythmias, including atrial flutter and fibrillation. We describe here the …

Hepatic dysfunction, most commonly an elevation of aminotransferases, develops in 15% to
40% of patients receiving amiodarone (1). However, acute hepatitis induced by parenteral …

Amiodarone, a commonly used antiarrhythmic agent, has numerous adverse effects. The
purpose of this case report is to highlight its hepatotoxicity, an unusual complication of long …